SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 145 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 1.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $83,001 | -19.8% | 3,590 | -9.0% | 0.05% | -18.0% |
| Q2 2023 | $103,464 | -6.8% | 3,946 | -8.5% | 0.06% | 0.0% |
| Q1 2023 | $111,042 | -28.6% | 4,314 | -27.8% | 0.06% | -24.7% |
| Q4 2022 | $155,488 | +5.8% | 5,978 | +16.1% | 0.08% | +37.3% |
| Q3 2022 | $147,000 | +16.7% | 5,151 | +0.8% | 0.06% | +25.5% |
| Q2 2022 | $126,000 | -2.3% | 5,111 | +123.4% | 0.05% | -19.0% |
| Q1 2022 | $129,000 | -14.0% | 2,288 | -5.6% | 0.06% | +1.8% |
| Q4 2021 | $150,000 | -10.2% | 2,425 | -8.1% | 0.06% | -21.9% |
| Q3 2021 | $167,000 | -27.1% | 2,640 | -4.8% | 0.07% | -22.3% |
| Q2 2021 | $229,000 | -22.4% | 2,774 | -30.8% | 0.09% | -24.8% |
| Q1 2021 | $295,000 | +3.1% | 4,006 | +1.7% | 0.12% | +5.0% |
| Q4 2020 | $286,000 | -16.4% | 3,940 | -45.0% | 0.12% | -33.5% |
| Q3 2020 | $342,000 | 0.0% | 7,168 | -12.0% | 0.18% | +10.5% |
| Q2 2020 | $342,000 | +1.8% | 8,149 | -34.5% | 0.16% | +17.4% |
| Q1 2020 | $336,000 | -38.8% | 12,448 | -12.7% | 0.14% | +53.3% |
| Q4 2019 | $549,000 | – | 14,253 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 3,081,307 | $71,239,818 | 7.97% |
| Finepoint Capital LP | 556,928 | $12,876,175 | 6.41% |
| M28 Capital Management LP | 197,700 | $4,570,824 | 5.24% |
| Boxer Capital, LLC | 3,421,541 | $79,106,028 | 4.21% |
| Deep Track Capital, LP | 3,546,435 | $81,993,577 | 3.16% |
| EcoR1 Capital, LLC | 3,460,208 | $80,000,009 | 2.70% |
| Orbimed Advisors | 3,968,588 | $91,753,755 | 1.95% |
| Artal Group S.A. | 1,816,620 | $42,000 | 1.80% |
| SPHERA FUNDS MANAGEMENT LTD. | 319,911 | $7,396,342 | 1.35% |
| Perceptive Advisors | 1,520,416 | $35,152,017 | 1.17% |